Skip to content

Atherosclerosis and Acute Ischemic Stroke Study

Carotid Atherosclerosis, Inflammation and Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03685006
Enrollment
500
Registered
2018-09-26
Start date
2009-01-01
Completion date
2030-01-01
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Inflammation, Ischemic Stroke

Brief summary

A significant proportion of strokes are thromboembolic in nature, arising from atherosclerotic plaque at the carotid bifurcation. It is now wellknown that inflammation plays a key role in atherogenesis and plaque destabilization. However the identification and characterization of the different inflammatory factors, as well as their relative importance, have not been clarified. This main aim of this study is to identify new risk markers for atherosclerosis and to characterize more precise methods for detection of the unstable carotid plaque with increased stroke-risk.

Detailed description

This project include patients with asymptomatic and symptomatic carotid stenosis \>50%. Patients with acute ischemic stroke will also be included with carotid artery stenosis \<50% (study 3). The patient group will undergo a clinical neurological examination, ultrasound of the neck-arteries and a blood sample. The majority will also have a CT-angiography of the neck arteries and a cerebral MRI or CT. Carotid plaques removed by surgery (carotid end-arterectomy) and thrombs removed by thrombectomy will undergo histological analyses. Study 1: Plasma markers will be analysed and compared to clinical symptoms, ultrasound assessment of the plaque, cerebral MRI (or CT). Study 2: Results from advanced ultrasound of the carotid plaque including assessment of plaque morphology will be compared to histology of the removed plaque. Plasma markers and clinic will be related to the findings. The correlation between the different diagnostic modalities and the histologic conclusion will be assessed. Study 3: This study focus on plasma markers in an acute ischemic stroke due to a carotid plaque compared to an acute ischemic stroke with a cardial embolic source. Thrombi removed from the cerebral artery by thrombectomy will undergo histological analysis and the results will be compared to plasma markers and stroke aetiology.

Interventions

None listed

Sponsors

University of Oslo
CollaboratorOTHER
University Hospital, Akershus
CollaboratorOTHER
Ostfold Hospital Trust
CollaboratorOTHER
Vestre Viken Hospital Trust
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* All patients with an atherosclerotic carotid stenosis \>50% admitting one of the study centres as an in-patient or an out-patient will be considered for inclusion. * Acute stroke patients treated with thrombectomy at Oslo University Hospital will be included even though the carotid stenosis is \< 50%.

Exclusion criteria

* Malign disease * Inflammatory disease

Design outcomes

Primary

MeasureTime frameDescription
Plasma markers and advanced ultrasound of neck arteries to detect plaque instability, predict stroke risk and correlation to stroke aetiology.one yearBlood test, ultrasound, cerebral MRI, clinical assessment

Secondary

MeasureTime frameDescription
Plasma markers to predict plaque instabilityAt inclusionBlood test, ultrasound, cerebral MRI
Advanced ultrasound for detection of carotid plaque instabilityAt inclusion and after one yearUltrasound, blood test, cerebral MRI, histology of carotid artery plaques
Plasma markers to determine correlation of acute ischemic stroke due to a carotid plaque compared to an acute ischemic stroke with a cardial embolic sourceAt inclusionBlood tests, ultrasound of neck arteries, cerebral MRI, histology of removed cerebral thrombi

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026